A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AHMAD, Akbar et al. Effects of the poly(ADP-RIBOSE) polymerase inhibitor olaparib in cerulein-induced pancreatitis. Shock, v. 53, n. 5, p. 653-665, 2020Tradução . . Disponível em: https://doi.org/10.1097/SHK.0000000000001402. Acesso em: 09 maio 2024.
APA
Ahmad, A., Mello, A. H. D., Szczesny, B., Toro, G., Marcatti, M., Druzhyna, N., et al. (2020). Effects of the poly(ADP-RIBOSE) polymerase inhibitor olaparib in cerulein-induced pancreatitis. Shock, 53( 5), 653-665. doi:10.1097/SHK.0000000000001402
NLM
Ahmad A, Mello AHD, Szczesny B, Toro G, Marcatti M, Druzhyna N, Liaudet L, Tarantini S, Salomao R, Soriano FG, Szabo C. Effects of the poly(ADP-RIBOSE) polymerase inhibitor olaparib in cerulein-induced pancreatitis [Internet]. Shock. 2020 ; 53( 5): 653-665.[citado 2024 maio 09 ] Available from: https://doi.org/10.1097/SHK.0000000000001402
Vancouver
Ahmad A, Mello AHD, Szczesny B, Toro G, Marcatti M, Druzhyna N, Liaudet L, Tarantini S, Salomao R, Soriano FG, Szabo C. Effects of the poly(ADP-RIBOSE) polymerase inhibitor olaparib in cerulein-induced pancreatitis [Internet]. Shock. 2020 ; 53( 5): 653-665.[citado 2024 maio 09 ] Available from: https://doi.org/10.1097/SHK.0000000000001402
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AHMAD, Akbar et al. The PARP inhibitor olaparib exerts beneficial effects in mice subjected to cecal ligature and puncture and in cells subjected to oxidative stress without impairing DNA integrity: A potential opportunity' for repurposing a clinically used oncological drug for the experimental therapy of sepsis. Pharmacological research, v. 145, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.phrs.2019.104263. Acesso em: 09 maio 2024.
APA
Ahmad, A., Vieira, J. de C., Mello, A. H. de, Lima, T. M. de, Ariga, S. K., Barbeiro, D. F., et al. (2019). The PARP inhibitor olaparib exerts beneficial effects in mice subjected to cecal ligature and puncture and in cells subjected to oxidative stress without impairing DNA integrity: A potential opportunity' for repurposing a clinically used oncological drug for the experimental therapy of sepsis. Pharmacological research, 145. doi:10.1016/j.phrs.2019.104263
NLM
Ahmad A, Vieira J de C, Mello AH de, Lima TM de, Ariga SK, Barbeiro DF, Barbeiro HV, Szczesny B, Toro G, Druzhyna N. The PARP inhibitor olaparib exerts beneficial effects in mice subjected to cecal ligature and puncture and in cells subjected to oxidative stress without impairing DNA integrity: A potential opportunity' for repurposing a clinically used oncological drug for the experimental therapy of sepsis [Internet]. Pharmacological research. 2019 ; 145[citado 2024 maio 09 ] Available from: https://doi.org/10.1016/j.phrs.2019.104263
Vancouver
Ahmad A, Vieira J de C, Mello AH de, Lima TM de, Ariga SK, Barbeiro DF, Barbeiro HV, Szczesny B, Toro G, Druzhyna N. The PARP inhibitor olaparib exerts beneficial effects in mice subjected to cecal ligature and puncture and in cells subjected to oxidative stress without impairing DNA integrity: A potential opportunity' for repurposing a clinically used oncological drug for the experimental therapy of sepsis [Internet]. Pharmacological research. 2019 ; 145[citado 2024 maio 09 ] Available from: https://doi.org/10.1016/j.phrs.2019.104263